Clinical Data gets FDA OK for depression drug
Associated Press Biotechnology company Clinical Data Inc. said this morning that the Food and Drug Administration approved the major depressive disorder treatment Viibryd. Clinical Data shares surged more than 40 percent in pre-market trading. The Newton company said the drug should be available in U.S. pharmacies in the second quarter. Clinical Data holds exclusive worldwide […]